Bromo-DragonFLY

Bromo-DragonFLY
Clinical data
Other names	Bromo-DragonFLY; 3C-Bromo-Dragonfly; DOB-Dragonfly; BDF; B-DFLY; DOB-DFLY
Identifiers
	IUPAC name 1-(4-bromofuro[2,3-f] [1]benzofuran-8-yl)propan-2-amine;
CAS Number	219986-94-4;
PubChem CID	9839057;
ChemSpider	8014776 ;
UNII	GC9M7R36OI;
ChEMBL	ChEMBL149024 ;
Chemical and physical data
Formula	C13H12BrNO2
Molar mass	294.148 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(N)Cc1c2ccoc2c(Br)c2ccoc12;
	InChI InChI=1S/C13H12BrNO2/c1-7(15)6-10-8-2-4-17-13(8)11(14)9-3-5-16-12(9)10/h2-5,7H,6,15H2,1H3 ; Key:GIKPTWKWYXCBEC-UHFFFAOYSA-N ;
	(what is this?) (verify)

Bromo-DragonFLY, also known as 3C-Bromo-Dragonfly or DOB-Dragonfly, psychedelic drug of the phenethylamine, DOx, and FLY families.^[2] It acts as a potent full agonist of the 5-HT_2A receptor.^[3]

^ "Bromo-DragonFLY". Forendex. USA: Southern Association of Forensic Scientists. Archived from the original on 6 October 2014. Retrieved 16 March 2012.
^ "Erowid Bromo-Dragonfly Vault". www.erowid.org. Archived from the original on 23 March 2018. Retrieved 26 March 2018.
^ Cite error: The named reference pmid9857084 was invoked but never defined (see the help page).